Lippman M E, Dickson R B
Lombardi Cancer Research Center, Georgetown University Medical Center, Washington, DC 20007.
Yale J Biol Med. 1989 Sep-Oct;62(5):459-80.
The multiple roles of both estrogenic and polypeptide regulators of mammary epithelial cell growth are reviewed in this article. Effects of both steroidal and peptide hormones are complex and involve multiple interactions with malignant cells and non-malignant host components. Initial carcinogenesis and progression of mammary epithelium to cancer probably require both proliferative stimuli (estrogen, polypeptide growth factors) and genetic damage. This condition may lead to qualitatively different hormonal responses (hormone-responsive cancer). Estrogens can be shown to induce growth-regulatory polypeptide growth factors and interact with them in hormone-dependent breast cancer. Progression of hormone-dependent (estrogen-responsive) breast cancer to hormone independence probably involves multiple mechanisms, including oncogene activation, loss of the estrogen receptor, or loss of hormone responsivity of other gene products. One direction for further therapies may be blockade of hormonal stimulation and interference with necessary activated or induced components of malignant progression such as oncogenes or polypeptide growth factor-receptor systems.
本文综述了雌激素和多肽对乳腺上皮细胞生长的多种调节作用。甾体激素和肽类激素的作用复杂,涉及与恶性细胞和非恶性宿主成分的多种相互作用。乳腺上皮细胞的初始致癌作用以及向癌症的进展可能既需要增殖刺激(雌激素、多肽生长因子),也需要基因损伤。这种情况可能导致性质不同的激素反应(激素反应性癌症)。在激素依赖性乳腺癌中,雌激素可诱导生长调节性多肽生长因子并与之相互作用。激素依赖性(雌激素反应性)乳腺癌向激素非依赖性的进展可能涉及多种机制,包括癌基因激活、雌激素受体丢失或其他基因产物的激素反应性丧失。进一步治疗的一个方向可能是阻断激素刺激,并干扰恶性进展所需的激活或诱导成分,如癌基因或多肽生长因子受体系统。